Global Immuno-oncology Diagnosis Market Insights, Forecast to 2029
This report presents an overview of global market for Immuno-oncology Diagnosis market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Immuno-oncology Diagnosis, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Immuno-oncology Diagnosis, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Immuno-oncology Diagnosis revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Immuno-oncology Diagnosis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Immuno-oncology Diagnosis revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including 10x Genomics, Abbott Laboratories, Abcam, Adaptive Biotechnologies, Aethlon Medical, Agena Bioscience, Angle plc, Apocell and ARUP Laboratories, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Immuno-oncology Diagnosis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immuno-oncology Diagnosis companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immuno-oncology Diagnosis revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
This report researches the key producers of Immuno-oncology Diagnosis, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Immuno-oncology Diagnosis, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Immuno-oncology Diagnosis revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Immuno-oncology Diagnosis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Immuno-oncology Diagnosis revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including 10x Genomics, Abbott Laboratories, Abcam, Adaptive Biotechnologies, Aethlon Medical, Agena Bioscience, Angle plc, Apocell and ARUP Laboratories, etc.
By Company
- 10x Genomics
- Abbott Laboratories
- Abcam
- Adaptive Biotechnologies
- Aethlon Medical
- Agena Bioscience
- Angle plc
- Apocell
- ARUP Laboratories
- Beckman Coulter
- Becton Dickinson
- Bioarray Genetics
- BioCartis
- Biocept
- Biodesix Inc
- BioFluidica
- BioGenex 40 bioMйrieux
- Bio-Rad
- Bio-Techne
- Bristol-Myers Squibb
- Cancer Genetics
- Caris Molecular Diagnostics
- CellMax Life
- Charles River Laboratories
- Chronix Biomedical
- Circulogene
- Clearbridge BioMedics
- Clinical Genomics
- Pfizer
- Promega
- Protagen Diagnostics
- Qiagen
- Quanterix
- Rarecells SAS
- Roche Diagnostics
- Siemens
- PCR
- NGS
- Immunoassay
- Research
- Diagnostics
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East, Africa, and Latin America
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Immuno-oncology Diagnosis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immuno-oncology Diagnosis companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immuno-oncology Diagnosis revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immuno-oncology Diagnosis Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 PCR
1.2.3 NGS
1.2.4 Immunoassay
1.3 Market by Application
1.3.1 Global Immuno-oncology Diagnosis Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Research
1.3.3 Diagnostics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Immuno-oncology Diagnosis Market Perspective (2018-2029)
2.2 Global Immuno-oncology Diagnosis Growth Trends by Region
2.2.1 Immuno-oncology Diagnosis Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Immuno-oncology Diagnosis Historic Market Size by Region (2018-2023)
2.2.3 Immuno-oncology Diagnosis Forecasted Market Size by Region (2024-2029)
2.3 Immuno-oncology Diagnosis Market Dynamics
2.3.1 Immuno-oncology Diagnosis Industry Trends
2.3.2 Immuno-oncology Diagnosis Market Drivers
2.3.3 Immuno-oncology Diagnosis Market Challenges
2.3.4 Immuno-oncology Diagnosis Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Immuno-oncology Diagnosis by Players
3.1.1 Global Immuno-oncology Diagnosis Revenue by Players (2018-2023)
3.1.2 Global Immuno-oncology Diagnosis Revenue Market Share by Players (2018-2023)
3.2 Global Immuno-oncology Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Immuno-oncology Diagnosis, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Immuno-oncology Diagnosis Market Concentration Ratio
3.4.1 Global Immuno-oncology Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immuno-oncology Diagnosis Revenue in 2022
3.5 Global Key Players of Immuno-oncology Diagnosis Head office and Area Served
3.6 Global Key Players of Immuno-oncology Diagnosis, Product and Application
3.7 Global Key Players of Immuno-oncology Diagnosis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 IMMUNO-ONCOLOGY DIAGNOSIS BREAKDOWN DATA BY TYPE
4.1 Global Immuno-oncology Diagnosis Historic Market Size by Type (2018-2023)
4.2 Global Immuno-oncology Diagnosis Forecasted Market Size by Type (2024-2029)
5 IMMUNO-ONCOLOGY DIAGNOSIS BREAKDOWN DATA BY APPLICATION
5.1 Global Immuno-oncology Diagnosis Historic Market Size by Application (2018-2023)
5.2 Global Immuno-oncology Diagnosis Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Immuno-oncology Diagnosis Market Size (2018-2029)
6.2 North America Immuno-oncology Diagnosis Market Size by Type
6.2.1 North America Immuno-oncology Diagnosis Market Size by Type (2018-2023)
6.2.2 North America Immuno-oncology Diagnosis Market Size by Type (2024-2029)
6.2.3 North America Immuno-oncology Diagnosis Market Share by Type (2018-2029)
6.3 North America Immuno-oncology Diagnosis Market Size by Application
6.3.1 North America Immuno-oncology Diagnosis Market Size by Application (2018-2023)
6.3.2 North America Immuno-oncology Diagnosis Market Size by Application (2024-2029)
6.3.3 North America Immuno-oncology Diagnosis Market Share by Application (2018-2029)
6.4 North America Immuno-oncology Diagnosis Market Size by Country
6.4.1 North America Immuno-oncology Diagnosis Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Immuno-oncology Diagnosis Market Size by Country (2018-2023)
6.4.3 North America Immuno-oncology Diagnosis Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe Immuno-oncology Diagnosis Market Size (2018-2029)
7.2 Europe Immuno-oncology Diagnosis Market Size by Type
7.2.1 Europe Immuno-oncology Diagnosis Market Size by Type (2018-2023)
7.2.2 Europe Immuno-oncology Diagnosis Market Size by Type (2024-2029)
7.2.3 Europe Immuno-oncology Diagnosis Market Share by Type (2018-2029)
7.3 Europe Immuno-oncology Diagnosis Market Size by Application
7.3.1 Europe Immuno-oncology Diagnosis Market Size by Application (2018-2023)
7.3.2 Europe Immuno-oncology Diagnosis Market Size by Application (2024-2029)
7.3.3 Europe Immuno-oncology Diagnosis Market Share by Application (2018-2029)
7.4 Europe Immuno-oncology Diagnosis Market Size by Country
7.4.1 Europe Immuno-oncology Diagnosis Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Immuno-oncology Diagnosis Market Size by Country (2018-2023)
7.4.3 Europe Immuno-oncology Diagnosis Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Immuno-oncology Diagnosis Market Size (2018-2029)
8.2 China Immuno-oncology Diagnosis Market Size by Type
8.2.1 China Immuno-oncology Diagnosis Market Size by Type (2018-2023)
8.2.2 China Immuno-oncology Diagnosis Market Size by Type (2024-2029)
8.2.3 China Immuno-oncology Diagnosis Market Share by Type (2018-2029)
8.3 China Immuno-oncology Diagnosis Market Size by Application
8.3.1 China Immuno-oncology Diagnosis Market Size by Application (2018-2023)
8.3.2 China Immuno-oncology Diagnosis Market Size by Application (2024-2029)
8.3.3 China Immuno-oncology Diagnosis Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Immuno-oncology Diagnosis Market Size (2018-2029)
9.2 Asia Immuno-oncology Diagnosis Market Size by Type
9.2.1 Asia Immuno-oncology Diagnosis Market Size by Type (2018-2023)
9.2.2 Asia Immuno-oncology Diagnosis Market Size by Type (2024-2029)
9.2.3 Asia Immuno-oncology Diagnosis Market Share by Type (2018-2029)
9.3 Asia Immuno-oncology Diagnosis Market Size by Application
9.3.1 Asia Immuno-oncology Diagnosis Market Size by Application (2018-2023)
9.3.2 Asia Immuno-oncology Diagnosis Market Size by Application (2024-2029)
9.3.3 Asia Immuno-oncology Diagnosis Market Share by Application (2018-2029)
9.4 Asia Immuno-oncology Diagnosis Market Size by Region
9.4.1 Asia Immuno-oncology Diagnosis Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Immuno-oncology Diagnosis Market Size by Region (2018-2023)
9.4.3 Asia Immuno-oncology Diagnosis Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Type
10.2.1 Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Application
10.3.1 Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Country
10.4.1 Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 10x Genomics
11.1.1 10x Genomics Company Details
11.1.2 10x Genomics Business Overview
11.1.3 10x Genomics Immuno-oncology Diagnosis Introduction
11.1.4 10x Genomics Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.1.5 10x Genomics Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Immuno-oncology Diagnosis Introduction
11.2.4 Abbott Laboratories Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.2.5 Abbott Laboratories Recent Developments
11.3 Abcam
11.3.1 Abcam Company Details
11.3.2 Abcam Business Overview
11.3.3 Abcam Immuno-oncology Diagnosis Introduction
11.3.4 Abcam Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.3.5 Abcam Recent Developments
11.4 Adaptive Biotechnologies
11.4.1 Adaptive Biotechnologies Company Details
11.4.2 Adaptive Biotechnologies Business Overview
11.4.3 Adaptive Biotechnologies Immuno-oncology Diagnosis Introduction
11.4.4 Adaptive Biotechnologies Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.4.5 Adaptive Biotechnologies Recent Developments
11.5 Aethlon Medical
11.5.1 Aethlon Medical Company Details
11.5.2 Aethlon Medical Business Overview
11.5.3 Aethlon Medical Immuno-oncology Diagnosis Introduction
11.5.4 Aethlon Medical Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.5.5 Aethlon Medical Recent Developments
11.6 Agena Bioscience
11.6.1 Agena Bioscience Company Details
11.6.2 Agena Bioscience Business Overview
11.6.3 Agena Bioscience Immuno-oncology Diagnosis Introduction
11.6.4 Agena Bioscience Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.6.5 Agena Bioscience Recent Developments
11.7 Angle plc
11.7.1 Angle plc Company Details
11.7.2 Angle plc Business Overview
11.7.3 Angle plc Immuno-oncology Diagnosis Introduction
11.7.4 Angle plc Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.7.5 Angle plc Recent Developments
11.8 Apocell
11.8.1 Apocell Company Details
11.8.2 Apocell Business Overview
11.8.3 Apocell Immuno-oncology Diagnosis Introduction
11.8.4 Apocell Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.8.5 Apocell Recent Developments
11.9 ARUP Laboratories
11.9.1 ARUP Laboratories Company Details
11.9.2 ARUP Laboratories Business Overview
11.9.3 ARUP Laboratories Immuno-oncology Diagnosis Introduction
11.9.4 ARUP Laboratories Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.9.5 ARUP Laboratories Recent Developments
11.10 Beckman Coulter
11.10.1 Beckman Coulter Company Details
11.10.2 Beckman Coulter Business Overview
11.10.3 Beckman Coulter Immuno-oncology Diagnosis Introduction
11.10.4 Beckman Coulter Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.10.5 Beckman Coulter Recent Developments
11.11 Becton Dickinson
11.11.1 Becton Dickinson Company Details
11.11.2 Becton Dickinson Business Overview
11.11.3 Becton Dickinson Immuno-oncology Diagnosis Introduction
11.11.4 Becton Dickinson Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.11.5 Becton Dickinson Recent Developments
11.12 Bioarray Genetics
11.12.1 Bioarray Genetics Company Details
11.12.2 Bioarray Genetics Business Overview
11.12.3 Bioarray Genetics Immuno-oncology Diagnosis Introduction
11.12.4 Bioarray Genetics Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.12.5 Bioarray Genetics Recent Developments
11.13 BioCartis
11.13.1 BioCartis Company Details
11.13.2 BioCartis Business Overview
11.13.3 BioCartis Immuno-oncology Diagnosis Introduction
11.13.4 BioCartis Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.13.5 BioCartis Recent Developments
11.14 Biocept
11.14.1 Biocept Company Details
11.14.2 Biocept Business Overview
11.14.3 Biocept Immuno-oncology Diagnosis Introduction
11.14.4 Biocept Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.14.5 Biocept Recent Developments
11.15 Biodesix Inc
11.15.1 Biodesix Inc Company Details
11.15.2 Biodesix Inc Business Overview
11.15.3 Biodesix Inc Immuno-oncology Diagnosis Introduction
11.15.4 Biodesix Inc Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.15.5 Biodesix Inc Recent Developments
11.16 BioFluidica
11.16.1 BioFluidica Company Details
11.16.2 BioFluidica Business Overview
11.16.3 BioFluidica Immuno-oncology Diagnosis Introduction
11.16.4 BioFluidica Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.16.5 BioFluidica Recent Developments
11.17 BioGenex 40 bioMйrieux
11.17.1 BioGenex 40 bioMйrieux Company Details
11.17.2 BioGenex 40 bioMйrieux Business Overview
11.17.3 BioGenex 40 bioMйrieux Immuno-oncology Diagnosis Introduction
11.17.4 BioGenex 40 bioMйrieux Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.17.5 BioGenex 40 bioMйrieux Recent Developments
11.18 Bio-Rad
11.18.1 Bio-Rad Company Details
11.18.2 Bio-Rad Business Overview
11.18.3 Bio-Rad Immuno-oncology Diagnosis Introduction
11.18.4 Bio-Rad Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.18.5 Bio-Rad Recent Developments
11.19 Bio-Techne
11.19.1 Bio-Techne Company Details
11.19.2 Bio-Techne Business Overview
11.19.3 Bio-Techne Immuno-oncology Diagnosis Introduction
11.19.4 Bio-Techne Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.19.5 Bio-Techne Recent Developments
11.20 Bristol-Myers Squibb
11.20.1 Bristol-Myers Squibb Company Details
11.20.2 Bristol-Myers Squibb Business Overview
11.20.3 Bristol-Myers Squibb Immuno-oncology Diagnosis Introduction
11.20.4 Bristol-Myers Squibb Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.20.5 Bristol-Myers Squibb Recent Developments
11.21 Cancer Genetics
11.21.1 Cancer Genetics Company Details
11.21.2 Cancer Genetics Business Overview
11.21.3 Cancer Genetics Immuno-oncology Diagnosis Introduction
11.21.4 Cancer Genetics Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.21.5 Cancer Genetics Recent Developments
11.22 Caris Molecular Diagnostics
11.22.1 Caris Molecular Diagnostics Company Details
11.22.2 Caris Molecular Diagnostics Business Overview
11.22.3 Caris Molecular Diagnostics Immuno-oncology Diagnosis Introduction
11.22.4 Caris Molecular Diagnostics Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.22.5 Caris Molecular Diagnostics Recent Developments
11.23 CellMax Life
11.23.1 CellMax Life Company Details
11.23.2 CellMax Life Business Overview
11.23.3 CellMax Life Immuno-oncology Diagnosis Introduction
11.23.4 CellMax Life Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.23.5 CellMax Life Recent Developments
11.24 Charles River Laboratories
11.24.1 Charles River Laboratories Company Details
11.24.2 Charles River Laboratories Business Overview
11.24.3 Charles River Laboratories Immuno-oncology Diagnosis Introduction
11.24.4 Charles River Laboratories Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.24.5 Charles River Laboratories Recent Developments
11.25 Chronix Biomedical
11.25.1 Chronix Biomedical Company Details
11.25.2 Chronix Biomedical Business Overview
11.25.3 Chronix Biomedical Immuno-oncology Diagnosis Introduction
11.25.4 Chronix Biomedical Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.25.5 Chronix Biomedical Recent Developments
11.26 Circulogene
11.26.1 Circulogene Company Details
11.26.2 Circulogene Business Overview
11.26.3 Circulogene Immuno-oncology Diagnosis Introduction
11.26.4 Circulogene Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.26.5 Circulogene Recent Developments
11.27 Clearbridge BioMedics
11.27.1 Clearbridge BioMedics Company Details
11.27.2 Clearbridge BioMedics Business Overview
11.27.3 Clearbridge BioMedics Immuno-oncology Diagnosis Introduction
11.27.4 Clearbridge BioMedics Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.27.5 Clearbridge BioMedics Recent Developments
11.28 Clinical Genomics
11.28.1 Clinical Genomics Company Details
11.28.2 Clinical Genomics Business Overview
11.28.3 Clinical Genomics Immuno-oncology Diagnosis Introduction
11.28.4 Clinical Genomics Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.28.5 Clinical Genomics Recent Developments
11.29 Pfizer
11.29.1 Pfizer Company Details
11.29.2 Pfizer Business Overview
11.29.3 Pfizer Immuno-oncology Diagnosis Introduction
11.29.4 Pfizer Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.29.5 Pfizer Recent Developments
11.30 Promega
11.30.1 Promega Company Details
11.30.2 Promega Business Overview
11.30.3 Promega Immuno-oncology Diagnosis Introduction
11.30.4 Promega Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.30.5 Promega Recent Developments
11.31 Protagen Diagnostics
11.31.1 Protagen Diagnostics Company Details
11.31.2 Protagen Diagnostics Business Overview
11.31.3 Protagen Diagnostics Immuno-oncology Diagnosis Introduction
11.31.4 Protagen Diagnostics Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.31.5 Protagen Diagnostics Recent Developments
11.32 Qiagen
11.32.1 Qiagen Company Details
11.32.2 Qiagen Business Overview
11.32.3 Qiagen Immuno-oncology Diagnosis Introduction
11.32.4 Qiagen Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.32.5 Qiagen Recent Developments
11.33 Quanterix
11.33.1 Quanterix Company Details
11.33.2 Quanterix Business Overview
11.33.3 Quanterix Immuno-oncology Diagnosis Introduction
11.33.4 Quanterix Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.33.5 Quanterix Recent Developments
11.34 Rarecells SAS
11.34.1 Rarecells SAS Company Details
11.34.2 Rarecells SAS Business Overview
11.34.3 Rarecells SAS Immuno-oncology Diagnosis Introduction
11.34.4 Rarecells SAS Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.34.5 Rarecells SAS Recent Developments
11.35 Roche Diagnostics
11.35.1 Roche Diagnostics Company Details
11.35.2 Roche Diagnostics Business Overview
11.35.3 Roche Diagnostics Immuno-oncology Diagnosis Introduction
11.35.4 Roche Diagnostics Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.35.5 Roche Diagnostics Recent Developments
11.36 Siemens
11.36.1 Siemens Company Details
11.36.2 Siemens Business Overview
11.36.3 Siemens Immuno-oncology Diagnosis Introduction
11.36.4 Siemens Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.36.5 Siemens Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immuno-oncology Diagnosis Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 PCR
1.2.3 NGS
1.2.4 Immunoassay
1.3 Market by Application
1.3.1 Global Immuno-oncology Diagnosis Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Research
1.3.3 Diagnostics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Immuno-oncology Diagnosis Market Perspective (2018-2029)
2.2 Global Immuno-oncology Diagnosis Growth Trends by Region
2.2.1 Immuno-oncology Diagnosis Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Immuno-oncology Diagnosis Historic Market Size by Region (2018-2023)
2.2.3 Immuno-oncology Diagnosis Forecasted Market Size by Region (2024-2029)
2.3 Immuno-oncology Diagnosis Market Dynamics
2.3.1 Immuno-oncology Diagnosis Industry Trends
2.3.2 Immuno-oncology Diagnosis Market Drivers
2.3.3 Immuno-oncology Diagnosis Market Challenges
2.3.4 Immuno-oncology Diagnosis Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Immuno-oncology Diagnosis by Players
3.1.1 Global Immuno-oncology Diagnosis Revenue by Players (2018-2023)
3.1.2 Global Immuno-oncology Diagnosis Revenue Market Share by Players (2018-2023)
3.2 Global Immuno-oncology Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Immuno-oncology Diagnosis, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Immuno-oncology Diagnosis Market Concentration Ratio
3.4.1 Global Immuno-oncology Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immuno-oncology Diagnosis Revenue in 2022
3.5 Global Key Players of Immuno-oncology Diagnosis Head office and Area Served
3.6 Global Key Players of Immuno-oncology Diagnosis, Product and Application
3.7 Global Key Players of Immuno-oncology Diagnosis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 IMMUNO-ONCOLOGY DIAGNOSIS BREAKDOWN DATA BY TYPE
4.1 Global Immuno-oncology Diagnosis Historic Market Size by Type (2018-2023)
4.2 Global Immuno-oncology Diagnosis Forecasted Market Size by Type (2024-2029)
5 IMMUNO-ONCOLOGY DIAGNOSIS BREAKDOWN DATA BY APPLICATION
5.1 Global Immuno-oncology Diagnosis Historic Market Size by Application (2018-2023)
5.2 Global Immuno-oncology Diagnosis Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Immuno-oncology Diagnosis Market Size (2018-2029)
6.2 North America Immuno-oncology Diagnosis Market Size by Type
6.2.1 North America Immuno-oncology Diagnosis Market Size by Type (2018-2023)
6.2.2 North America Immuno-oncology Diagnosis Market Size by Type (2024-2029)
6.2.3 North America Immuno-oncology Diagnosis Market Share by Type (2018-2029)
6.3 North America Immuno-oncology Diagnosis Market Size by Application
6.3.1 North America Immuno-oncology Diagnosis Market Size by Application (2018-2023)
6.3.2 North America Immuno-oncology Diagnosis Market Size by Application (2024-2029)
6.3.3 North America Immuno-oncology Diagnosis Market Share by Application (2018-2029)
6.4 North America Immuno-oncology Diagnosis Market Size by Country
6.4.1 North America Immuno-oncology Diagnosis Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Immuno-oncology Diagnosis Market Size by Country (2018-2023)
6.4.3 North America Immuno-oncology Diagnosis Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe Immuno-oncology Diagnosis Market Size (2018-2029)
7.2 Europe Immuno-oncology Diagnosis Market Size by Type
7.2.1 Europe Immuno-oncology Diagnosis Market Size by Type (2018-2023)
7.2.2 Europe Immuno-oncology Diagnosis Market Size by Type (2024-2029)
7.2.3 Europe Immuno-oncology Diagnosis Market Share by Type (2018-2029)
7.3 Europe Immuno-oncology Diagnosis Market Size by Application
7.3.1 Europe Immuno-oncology Diagnosis Market Size by Application (2018-2023)
7.3.2 Europe Immuno-oncology Diagnosis Market Size by Application (2024-2029)
7.3.3 Europe Immuno-oncology Diagnosis Market Share by Application (2018-2029)
7.4 Europe Immuno-oncology Diagnosis Market Size by Country
7.4.1 Europe Immuno-oncology Diagnosis Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Immuno-oncology Diagnosis Market Size by Country (2018-2023)
7.4.3 Europe Immuno-oncology Diagnosis Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Immuno-oncology Diagnosis Market Size (2018-2029)
8.2 China Immuno-oncology Diagnosis Market Size by Type
8.2.1 China Immuno-oncology Diagnosis Market Size by Type (2018-2023)
8.2.2 China Immuno-oncology Diagnosis Market Size by Type (2024-2029)
8.2.3 China Immuno-oncology Diagnosis Market Share by Type (2018-2029)
8.3 China Immuno-oncology Diagnosis Market Size by Application
8.3.1 China Immuno-oncology Diagnosis Market Size by Application (2018-2023)
8.3.2 China Immuno-oncology Diagnosis Market Size by Application (2024-2029)
8.3.3 China Immuno-oncology Diagnosis Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Immuno-oncology Diagnosis Market Size (2018-2029)
9.2 Asia Immuno-oncology Diagnosis Market Size by Type
9.2.1 Asia Immuno-oncology Diagnosis Market Size by Type (2018-2023)
9.2.2 Asia Immuno-oncology Diagnosis Market Size by Type (2024-2029)
9.2.3 Asia Immuno-oncology Diagnosis Market Share by Type (2018-2029)
9.3 Asia Immuno-oncology Diagnosis Market Size by Application
9.3.1 Asia Immuno-oncology Diagnosis Market Size by Application (2018-2023)
9.3.2 Asia Immuno-oncology Diagnosis Market Size by Application (2024-2029)
9.3.3 Asia Immuno-oncology Diagnosis Market Share by Application (2018-2029)
9.4 Asia Immuno-oncology Diagnosis Market Size by Region
9.4.1 Asia Immuno-oncology Diagnosis Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Immuno-oncology Diagnosis Market Size by Region (2018-2023)
9.4.3 Asia Immuno-oncology Diagnosis Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Type
10.2.1 Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Application
10.3.1 Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Country
10.4.1 Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 10x Genomics
11.1.1 10x Genomics Company Details
11.1.2 10x Genomics Business Overview
11.1.3 10x Genomics Immuno-oncology Diagnosis Introduction
11.1.4 10x Genomics Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.1.5 10x Genomics Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Immuno-oncology Diagnosis Introduction
11.2.4 Abbott Laboratories Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.2.5 Abbott Laboratories Recent Developments
11.3 Abcam
11.3.1 Abcam Company Details
11.3.2 Abcam Business Overview
11.3.3 Abcam Immuno-oncology Diagnosis Introduction
11.3.4 Abcam Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.3.5 Abcam Recent Developments
11.4 Adaptive Biotechnologies
11.4.1 Adaptive Biotechnologies Company Details
11.4.2 Adaptive Biotechnologies Business Overview
11.4.3 Adaptive Biotechnologies Immuno-oncology Diagnosis Introduction
11.4.4 Adaptive Biotechnologies Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.4.5 Adaptive Biotechnologies Recent Developments
11.5 Aethlon Medical
11.5.1 Aethlon Medical Company Details
11.5.2 Aethlon Medical Business Overview
11.5.3 Aethlon Medical Immuno-oncology Diagnosis Introduction
11.5.4 Aethlon Medical Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.5.5 Aethlon Medical Recent Developments
11.6 Agena Bioscience
11.6.1 Agena Bioscience Company Details
11.6.2 Agena Bioscience Business Overview
11.6.3 Agena Bioscience Immuno-oncology Diagnosis Introduction
11.6.4 Agena Bioscience Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.6.5 Agena Bioscience Recent Developments
11.7 Angle plc
11.7.1 Angle plc Company Details
11.7.2 Angle plc Business Overview
11.7.3 Angle plc Immuno-oncology Diagnosis Introduction
11.7.4 Angle plc Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.7.5 Angle plc Recent Developments
11.8 Apocell
11.8.1 Apocell Company Details
11.8.2 Apocell Business Overview
11.8.3 Apocell Immuno-oncology Diagnosis Introduction
11.8.4 Apocell Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.8.5 Apocell Recent Developments
11.9 ARUP Laboratories
11.9.1 ARUP Laboratories Company Details
11.9.2 ARUP Laboratories Business Overview
11.9.3 ARUP Laboratories Immuno-oncology Diagnosis Introduction
11.9.4 ARUP Laboratories Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.9.5 ARUP Laboratories Recent Developments
11.10 Beckman Coulter
11.10.1 Beckman Coulter Company Details
11.10.2 Beckman Coulter Business Overview
11.10.3 Beckman Coulter Immuno-oncology Diagnosis Introduction
11.10.4 Beckman Coulter Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.10.5 Beckman Coulter Recent Developments
11.11 Becton Dickinson
11.11.1 Becton Dickinson Company Details
11.11.2 Becton Dickinson Business Overview
11.11.3 Becton Dickinson Immuno-oncology Diagnosis Introduction
11.11.4 Becton Dickinson Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.11.5 Becton Dickinson Recent Developments
11.12 Bioarray Genetics
11.12.1 Bioarray Genetics Company Details
11.12.2 Bioarray Genetics Business Overview
11.12.3 Bioarray Genetics Immuno-oncology Diagnosis Introduction
11.12.4 Bioarray Genetics Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.12.5 Bioarray Genetics Recent Developments
11.13 BioCartis
11.13.1 BioCartis Company Details
11.13.2 BioCartis Business Overview
11.13.3 BioCartis Immuno-oncology Diagnosis Introduction
11.13.4 BioCartis Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.13.5 BioCartis Recent Developments
11.14 Biocept
11.14.1 Biocept Company Details
11.14.2 Biocept Business Overview
11.14.3 Biocept Immuno-oncology Diagnosis Introduction
11.14.4 Biocept Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.14.5 Biocept Recent Developments
11.15 Biodesix Inc
11.15.1 Biodesix Inc Company Details
11.15.2 Biodesix Inc Business Overview
11.15.3 Biodesix Inc Immuno-oncology Diagnosis Introduction
11.15.4 Biodesix Inc Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.15.5 Biodesix Inc Recent Developments
11.16 BioFluidica
11.16.1 BioFluidica Company Details
11.16.2 BioFluidica Business Overview
11.16.3 BioFluidica Immuno-oncology Diagnosis Introduction
11.16.4 BioFluidica Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.16.5 BioFluidica Recent Developments
11.17 BioGenex 40 bioMйrieux
11.17.1 BioGenex 40 bioMйrieux Company Details
11.17.2 BioGenex 40 bioMйrieux Business Overview
11.17.3 BioGenex 40 bioMйrieux Immuno-oncology Diagnosis Introduction
11.17.4 BioGenex 40 bioMйrieux Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.17.5 BioGenex 40 bioMйrieux Recent Developments
11.18 Bio-Rad
11.18.1 Bio-Rad Company Details
11.18.2 Bio-Rad Business Overview
11.18.3 Bio-Rad Immuno-oncology Diagnosis Introduction
11.18.4 Bio-Rad Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.18.5 Bio-Rad Recent Developments
11.19 Bio-Techne
11.19.1 Bio-Techne Company Details
11.19.2 Bio-Techne Business Overview
11.19.3 Bio-Techne Immuno-oncology Diagnosis Introduction
11.19.4 Bio-Techne Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.19.5 Bio-Techne Recent Developments
11.20 Bristol-Myers Squibb
11.20.1 Bristol-Myers Squibb Company Details
11.20.2 Bristol-Myers Squibb Business Overview
11.20.3 Bristol-Myers Squibb Immuno-oncology Diagnosis Introduction
11.20.4 Bristol-Myers Squibb Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.20.5 Bristol-Myers Squibb Recent Developments
11.21 Cancer Genetics
11.21.1 Cancer Genetics Company Details
11.21.2 Cancer Genetics Business Overview
11.21.3 Cancer Genetics Immuno-oncology Diagnosis Introduction
11.21.4 Cancer Genetics Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.21.5 Cancer Genetics Recent Developments
11.22 Caris Molecular Diagnostics
11.22.1 Caris Molecular Diagnostics Company Details
11.22.2 Caris Molecular Diagnostics Business Overview
11.22.3 Caris Molecular Diagnostics Immuno-oncology Diagnosis Introduction
11.22.4 Caris Molecular Diagnostics Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.22.5 Caris Molecular Diagnostics Recent Developments
11.23 CellMax Life
11.23.1 CellMax Life Company Details
11.23.2 CellMax Life Business Overview
11.23.3 CellMax Life Immuno-oncology Diagnosis Introduction
11.23.4 CellMax Life Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.23.5 CellMax Life Recent Developments
11.24 Charles River Laboratories
11.24.1 Charles River Laboratories Company Details
11.24.2 Charles River Laboratories Business Overview
11.24.3 Charles River Laboratories Immuno-oncology Diagnosis Introduction
11.24.4 Charles River Laboratories Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.24.5 Charles River Laboratories Recent Developments
11.25 Chronix Biomedical
11.25.1 Chronix Biomedical Company Details
11.25.2 Chronix Biomedical Business Overview
11.25.3 Chronix Biomedical Immuno-oncology Diagnosis Introduction
11.25.4 Chronix Biomedical Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.25.5 Chronix Biomedical Recent Developments
11.26 Circulogene
11.26.1 Circulogene Company Details
11.26.2 Circulogene Business Overview
11.26.3 Circulogene Immuno-oncology Diagnosis Introduction
11.26.4 Circulogene Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.26.5 Circulogene Recent Developments
11.27 Clearbridge BioMedics
11.27.1 Clearbridge BioMedics Company Details
11.27.2 Clearbridge BioMedics Business Overview
11.27.3 Clearbridge BioMedics Immuno-oncology Diagnosis Introduction
11.27.4 Clearbridge BioMedics Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.27.5 Clearbridge BioMedics Recent Developments
11.28 Clinical Genomics
11.28.1 Clinical Genomics Company Details
11.28.2 Clinical Genomics Business Overview
11.28.3 Clinical Genomics Immuno-oncology Diagnosis Introduction
11.28.4 Clinical Genomics Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.28.5 Clinical Genomics Recent Developments
11.29 Pfizer
11.29.1 Pfizer Company Details
11.29.2 Pfizer Business Overview
11.29.3 Pfizer Immuno-oncology Diagnosis Introduction
11.29.4 Pfizer Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.29.5 Pfizer Recent Developments
11.30 Promega
11.30.1 Promega Company Details
11.30.2 Promega Business Overview
11.30.3 Promega Immuno-oncology Diagnosis Introduction
11.30.4 Promega Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.30.5 Promega Recent Developments
11.31 Protagen Diagnostics
11.31.1 Protagen Diagnostics Company Details
11.31.2 Protagen Diagnostics Business Overview
11.31.3 Protagen Diagnostics Immuno-oncology Diagnosis Introduction
11.31.4 Protagen Diagnostics Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.31.5 Protagen Diagnostics Recent Developments
11.32 Qiagen
11.32.1 Qiagen Company Details
11.32.2 Qiagen Business Overview
11.32.3 Qiagen Immuno-oncology Diagnosis Introduction
11.32.4 Qiagen Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.32.5 Qiagen Recent Developments
11.33 Quanterix
11.33.1 Quanterix Company Details
11.33.2 Quanterix Business Overview
11.33.3 Quanterix Immuno-oncology Diagnosis Introduction
11.33.4 Quanterix Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.33.5 Quanterix Recent Developments
11.34 Rarecells SAS
11.34.1 Rarecells SAS Company Details
11.34.2 Rarecells SAS Business Overview
11.34.3 Rarecells SAS Immuno-oncology Diagnosis Introduction
11.34.4 Rarecells SAS Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.34.5 Rarecells SAS Recent Developments
11.35 Roche Diagnostics
11.35.1 Roche Diagnostics Company Details
11.35.2 Roche Diagnostics Business Overview
11.35.3 Roche Diagnostics Immuno-oncology Diagnosis Introduction
11.35.4 Roche Diagnostics Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.35.5 Roche Diagnostics Recent Developments
11.36 Siemens
11.36.1 Siemens Company Details
11.36.2 Siemens Business Overview
11.36.3 Siemens Immuno-oncology Diagnosis Introduction
11.36.4 Siemens Revenue in Immuno-oncology Diagnosis Business (2018-2023)
11.36.5 Siemens Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Immuno-oncology Diagnosis Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of PCR
Table 3. Key Players of NGS
Table 4. Key Players of Immunoassay
Table 5. Global Immuno-oncology Diagnosis Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Immuno-oncology Diagnosis Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Immuno-oncology Diagnosis Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Immuno-oncology Diagnosis Market Share by Region (2018-2023)
Table 9. Global Immuno-oncology Diagnosis Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Immuno-oncology Diagnosis Market Share by Region (2024-2029)
Table 11. Immuno-oncology Diagnosis Market Trends
Table 12. Immuno-oncology Diagnosis Market Drivers
Table 13. Immuno-oncology Diagnosis Market Challenges
Table 14. Immuno-oncology Diagnosis Market Restraints
Table 15. Global Immuno-oncology Diagnosis Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Immuno-oncology Diagnosis Revenue Share by Players (2018-2023)
Table 17. Global Top Immuno-oncology Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-oncology Diagnosis as of 2022)
Table 18. Global Immuno-oncology Diagnosis Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Immuno-oncology Diagnosis Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Immuno-oncology Diagnosis, Headquarters and Area Served
Table 21. Global Key Players of Immuno-oncology Diagnosis, Product and Application
Table 22. Global Key Players of Immuno-oncology Diagnosis, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Immuno-oncology Diagnosis Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Immuno-oncology Diagnosis Revenue Market Share by Type (2018-2023)
Table 26. Global Immuno-oncology Diagnosis Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Immuno-oncology Diagnosis Revenue Market Share by Type (2024-2029)
Table 28. Global Immuno-oncology Diagnosis Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Immuno-oncology Diagnosis Revenue Share by Application (2018-2023)
Table 30. Global Immuno-oncology Diagnosis Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Immuno-oncology Diagnosis Revenue Share by Application (2024-2029)
Table 32. North America Immuno-oncology Diagnosis Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Immuno-oncology Diagnosis Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Immuno-oncology Diagnosis Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Immuno-oncology Diagnosis Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Immuno-oncology Diagnosis Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Immuno-oncology Diagnosis Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Immuno-oncology Diagnosis Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Immuno-oncology Diagnosis Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Immuno-oncology Diagnosis Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Immuno-oncology Diagnosis Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Immuno-oncology Diagnosis Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Immuno-oncology Diagnosis Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Immuno-oncology Diagnosis Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Immuno-oncology Diagnosis Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Immuno-oncology Diagnosis Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Immuno-oncology Diagnosis Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Immuno-oncology Diagnosis Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Immuno-oncology Diagnosis Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Immuno-oncology Diagnosis Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Immuno-oncology Diagnosis Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Immuno-oncology Diagnosis Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Immuno-oncology Diagnosis Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Immuno-oncology Diagnosis Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Immuno-oncology Diagnosis Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Immuno-oncology Diagnosis Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Immuno-oncology Diagnosis Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Country (2024-2029) & (US$ Million)
Table 64. 10x Genomics Company Details
Table 65. 10x Genomics Business Overview
Table 66. 10x Genomics Immuno-oncology Diagnosis Product
Table 67. 10x Genomics Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 68. 10x Genomics Recent Developments
Table 69. Abbott Laboratories Company Details
Table 70. Abbott Laboratories Business Overview
Table 71. Abbott Laboratories Immuno-oncology Diagnosis Product
Table 72. Abbott Laboratories Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 73. Abbott Laboratories Recent Developments
Table 74. Abcam Company Details
Table 75. Abcam Business Overview
Table 76. Abcam Immuno-oncology Diagnosis Product
Table 77. Abcam Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 78. Abcam Recent Developments
Table 79. Adaptive Biotechnologies Company Details
Table 80. Adaptive Biotechnologies Business Overview
Table 81. Adaptive Biotechnologies Immuno-oncology Diagnosis Product
Table 82. Adaptive Biotechnologies Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 83. Adaptive Biotechnologies Recent Developments
Table 84. Aethlon Medical Company Details
Table 85. Aethlon Medical Business Overview
Table 86. Aethlon Medical Immuno-oncology Diagnosis Product
Table 87. Aethlon Medical Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 88. Aethlon Medical Recent Developments
Table 89. Agena Bioscience Company Details
Table 90. Agena Bioscience Business Overview
Table 91. Agena Bioscience Immuno-oncology Diagnosis Product
Table 92. Agena Bioscience Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 93. Agena Bioscience Recent Developments
Table 94. Angle plc Company Details
Table 95. Angle plc Business Overview
Table 96. Angle plc Immuno-oncology Diagnosis Product
Table 97. Angle plc Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 98. Angle plc Recent Developments
Table 99. Apocell Company Details
Table 100. Apocell Business Overview
Table 101. Apocell Immuno-oncology Diagnosis Product
Table 102. Apocell Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 103. Apocell Recent Developments
Table 104. ARUP Laboratories Company Details
Table 105. ARUP Laboratories Business Overview
Table 106. ARUP Laboratories Immuno-oncology Diagnosis Product
Table 107. ARUP Laboratories Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 108. ARUP Laboratories Recent Developments
Table 109. Beckman Coulter Company Details
Table 110. Beckman Coulter Business Overview
Table 111. Beckman Coulter Immuno-oncology Diagnosis Product
Table 112. Beckman Coulter Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 113. Beckman Coulter Recent Developments
Table 114. Becton Dickinson Company Details
Table 115. Becton Dickinson Business Overview
Table 116. Becton Dickinson Immuno-oncology Diagnosis Product
Table 117. Becton Dickinson Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 118. Becton Dickinson Recent Developments
Table 119. Bioarray Genetics Company Details
Table 120. Bioarray Genetics Business Overview
Table 121. Bioarray Genetics Immuno-oncology Diagnosis Product
Table 122. Bioarray Genetics Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 123. Bioarray Genetics Recent Developments
Table 124. BioCartis Company Details
Table 125. BioCartis Business Overview
Table 126. BioCartis Immuno-oncology Diagnosis Product
Table 127. BioCartis Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 128. BioCartis Recent Developments
Table 129. Biocept Company Details
Table 130. Biocept Business Overview
Table 131. Biocept Immuno-oncology Diagnosis Product
Table 132. Biocept Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 133. Biocept Recent Developments
Table 134. Biodesix Inc Company Details
Table 135. Biodesix Inc Business Overview
Table 136. Biodesix Inc Immuno-oncology Diagnosis Product
Table 137. Biodesix Inc Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 138. Biodesix Inc Recent Developments
Table 139. BioFluidica Company Details
Table 140. BioFluidica Business Overview
Table 141. BioFluidica Immuno-oncology Diagnosis Product
Table 142. BioFluidica Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 143. BioFluidica Recent Developments
Table 144. BioGenex 40 bioMйrieux Company Details
Table 145. BioGenex 40 bioMйrieux Business Overview
Table 146. BioGenex 40 bioMйrieux Immuno-oncology Diagnosis Product
Table 147. BioGenex 40 bioMйrieux Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 148. BioGenex 40 bioMйrieux Recent Developments
Table 149. Bio-Rad Company Details
Table 150. Bio-Rad Business Overview
Table 151. Bio-Rad Immuno-oncology Diagnosis Product
Table 152. Bio-Rad Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 153. Bio-Rad Recent Developments
Table 154. Bio-Techne Company Details
Table 155. Bio-Techne Business Overview
Table 156. Bio-Techne Immuno-oncology Diagnosis Product
Table 157. Bio-Techne Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 158. Bio-Techne Recent Developments
Table 159. Bristol-Myers Squibb Company Details
Table 160. Bristol-Myers Squibb Business Overview
Table 161. Bristol-Myers Squibb Immuno-oncology Diagnosis Product
Table 162. Bristol-Myers Squibb Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 163. Bristol-Myers Squibb Recent Developments
Table 164. Cancer Genetics Company Details
Table 165. Cancer Genetics Business Overview
Table 166. Cancer Genetics Immuno-oncology Diagnosis Product
Table 167. Cancer Genetics Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 168. Cancer Genetics Recent Developments
Table 169. Caris Molecular Diagnostics Company Details
Table 170. Caris Molecular Diagnostics Business Overview
Table 171. Caris Molecular Diagnostics Immuno-oncology Diagnosis Product
Table 172. Caris Molecular Diagnostics Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 173. Caris Molecular Diagnostics Recent Developments
Table 174. CellMax Life Company Details
Table 175. CellMax Life Business Overview
Table 176. CellMax Life Immuno-oncology Diagnosis Product
Table 177. CellMax Life Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 178. CellMax Life Recent Developments
Table 179. Charles River Laboratories Company Details
Table 180. Charles River Laboratories Business Overview
Table 181. Charles River Laboratories Immuno-oncology Diagnosis Product
Table 182. Charles River Laboratories Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 183. Charles River Laboratories Recent Developments
Table 184. Chronix Biomedical Company Details
Table 185. Chronix Biomedical Business Overview
Table 186. Chronix Biomedical Immuno-oncology Diagnosis Product
Table 187. Chronix Biomedical Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 188. Chronix Biomedical Recent Developments
Table 189. Circulogene Company Details
Table 190. Circulogene Business Overview
Table 191. Circulogene Immuno-oncology Diagnosis Product
Table 192. Circulogene Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 193. Circulogene Recent Developments
Table 194. Clearbridge BioMedics Company Details
Table 195. Clearbridge BioMedics Business Overview
Table 196. Clearbridge BioMedics Immuno-oncology Diagnosis Product
Table 197. Clearbridge BioMedics Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 198. Clearbridge BioMedics Recent Developments
Table 199. Clinical Genomics Company Details
Table 200. Clinical Genomics Business Overview
Table 201. Clinical Genomics Immuno-oncology Diagnosis Product
Table 202. Clinical Genomics Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 203. Clinical Genomics Recent Developments
Table 204. Pfizer Company Details
Table 205. Pfizer Business Overview
Table 206. Pfizer Immuno-oncology Diagnosis Product
Table 207. Pfizer Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 208. Pfizer Recent Developments
Table 209. Promega Company Details
Table 210. Promega Business Overview
Table 211. Promega Immuno-oncology Diagnosis Product
Table 212. Promega Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 213. Promega Recent Developments
Table 214. Protagen Diagnostics Company Details
Table 215. Protagen Diagnostics Business Overview
Table 216. Protagen Diagnostics Immuno-oncology Diagnosis Product
Table 217. Protagen Diagnostics Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 218. Protagen Diagnostics Recent Developments
Table 219. Qiagen Company Details
Table 220. Qiagen Business Overview
Table 221. Qiagen Immuno-oncology Diagnosis Product
Table 222. Qiagen Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 223. Qiagen Recent Developments
Table 224. Quanterix Company Details
Table 225. Quanterix Business Overview
Table 226. Quanterix Immuno-oncology Diagnosis Product
Table 227. Quanterix Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 228. Quanterix Recent Developments
Table 229. Rarecells SAS Company Details
Table 230. Rarecells SAS Business Overview
Table 231. Rarecells SAS Immuno-oncology Diagnosis Product
Table 232. Rarecells SAS Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 233. Rarecells SAS Recent Developments
Table 234. Roche Diagnostics Company Details
Table 235. Roche Diagnostics Business Overview
Table 236. Roche Diagnostics Immuno-oncology Diagnosis Product
Table 237. Roche Diagnostics Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 238. Roche Diagnostics Recent Developments
Table 239. Siemens Company Details
Table 240. Siemens Business Overview
Table 241. Siemens Immuno-oncology Diagnosis Product
Table 242. Siemens Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 243. Siemens Recent Development
Table 244. Research Programs/Design for This Report
Table 245. Key Data Information from Secondary Sources
Table 246. Key Data Information from Primary Sources
Table 1. Global Immuno-oncology Diagnosis Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of PCR
Table 3. Key Players of NGS
Table 4. Key Players of Immunoassay
Table 5. Global Immuno-oncology Diagnosis Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Immuno-oncology Diagnosis Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Immuno-oncology Diagnosis Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Immuno-oncology Diagnosis Market Share by Region (2018-2023)
Table 9. Global Immuno-oncology Diagnosis Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Immuno-oncology Diagnosis Market Share by Region (2024-2029)
Table 11. Immuno-oncology Diagnosis Market Trends
Table 12. Immuno-oncology Diagnosis Market Drivers
Table 13. Immuno-oncology Diagnosis Market Challenges
Table 14. Immuno-oncology Diagnosis Market Restraints
Table 15. Global Immuno-oncology Diagnosis Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Immuno-oncology Diagnosis Revenue Share by Players (2018-2023)
Table 17. Global Top Immuno-oncology Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-oncology Diagnosis as of 2022)
Table 18. Global Immuno-oncology Diagnosis Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Immuno-oncology Diagnosis Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Immuno-oncology Diagnosis, Headquarters and Area Served
Table 21. Global Key Players of Immuno-oncology Diagnosis, Product and Application
Table 22. Global Key Players of Immuno-oncology Diagnosis, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Immuno-oncology Diagnosis Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Immuno-oncology Diagnosis Revenue Market Share by Type (2018-2023)
Table 26. Global Immuno-oncology Diagnosis Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Immuno-oncology Diagnosis Revenue Market Share by Type (2024-2029)
Table 28. Global Immuno-oncology Diagnosis Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Immuno-oncology Diagnosis Revenue Share by Application (2018-2023)
Table 30. Global Immuno-oncology Diagnosis Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Immuno-oncology Diagnosis Revenue Share by Application (2024-2029)
Table 32. North America Immuno-oncology Diagnosis Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Immuno-oncology Diagnosis Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Immuno-oncology Diagnosis Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Immuno-oncology Diagnosis Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Immuno-oncology Diagnosis Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Immuno-oncology Diagnosis Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Immuno-oncology Diagnosis Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Immuno-oncology Diagnosis Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Immuno-oncology Diagnosis Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Immuno-oncology Diagnosis Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Immuno-oncology Diagnosis Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Immuno-oncology Diagnosis Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Immuno-oncology Diagnosis Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Immuno-oncology Diagnosis Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Immuno-oncology Diagnosis Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Immuno-oncology Diagnosis Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Immuno-oncology Diagnosis Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Immuno-oncology Diagnosis Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Immuno-oncology Diagnosis Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Immuno-oncology Diagnosis Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Immuno-oncology Diagnosis Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Immuno-oncology Diagnosis Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Immuno-oncology Diagnosis Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Immuno-oncology Diagnosis Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Immuno-oncology Diagnosis Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Immuno-oncology Diagnosis Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size by Country (2024-2029) & (US$ Million)
Table 64. 10x Genomics Company Details
Table 65. 10x Genomics Business Overview
Table 66. 10x Genomics Immuno-oncology Diagnosis Product
Table 67. 10x Genomics Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 68. 10x Genomics Recent Developments
Table 69. Abbott Laboratories Company Details
Table 70. Abbott Laboratories Business Overview
Table 71. Abbott Laboratories Immuno-oncology Diagnosis Product
Table 72. Abbott Laboratories Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 73. Abbott Laboratories Recent Developments
Table 74. Abcam Company Details
Table 75. Abcam Business Overview
Table 76. Abcam Immuno-oncology Diagnosis Product
Table 77. Abcam Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 78. Abcam Recent Developments
Table 79. Adaptive Biotechnologies Company Details
Table 80. Adaptive Biotechnologies Business Overview
Table 81. Adaptive Biotechnologies Immuno-oncology Diagnosis Product
Table 82. Adaptive Biotechnologies Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 83. Adaptive Biotechnologies Recent Developments
Table 84. Aethlon Medical Company Details
Table 85. Aethlon Medical Business Overview
Table 86. Aethlon Medical Immuno-oncology Diagnosis Product
Table 87. Aethlon Medical Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 88. Aethlon Medical Recent Developments
Table 89. Agena Bioscience Company Details
Table 90. Agena Bioscience Business Overview
Table 91. Agena Bioscience Immuno-oncology Diagnosis Product
Table 92. Agena Bioscience Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 93. Agena Bioscience Recent Developments
Table 94. Angle plc Company Details
Table 95. Angle plc Business Overview
Table 96. Angle plc Immuno-oncology Diagnosis Product
Table 97. Angle plc Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 98. Angle plc Recent Developments
Table 99. Apocell Company Details
Table 100. Apocell Business Overview
Table 101. Apocell Immuno-oncology Diagnosis Product
Table 102. Apocell Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 103. Apocell Recent Developments
Table 104. ARUP Laboratories Company Details
Table 105. ARUP Laboratories Business Overview
Table 106. ARUP Laboratories Immuno-oncology Diagnosis Product
Table 107. ARUP Laboratories Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 108. ARUP Laboratories Recent Developments
Table 109. Beckman Coulter Company Details
Table 110. Beckman Coulter Business Overview
Table 111. Beckman Coulter Immuno-oncology Diagnosis Product
Table 112. Beckman Coulter Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 113. Beckman Coulter Recent Developments
Table 114. Becton Dickinson Company Details
Table 115. Becton Dickinson Business Overview
Table 116. Becton Dickinson Immuno-oncology Diagnosis Product
Table 117. Becton Dickinson Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 118. Becton Dickinson Recent Developments
Table 119. Bioarray Genetics Company Details
Table 120. Bioarray Genetics Business Overview
Table 121. Bioarray Genetics Immuno-oncology Diagnosis Product
Table 122. Bioarray Genetics Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 123. Bioarray Genetics Recent Developments
Table 124. BioCartis Company Details
Table 125. BioCartis Business Overview
Table 126. BioCartis Immuno-oncology Diagnosis Product
Table 127. BioCartis Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 128. BioCartis Recent Developments
Table 129. Biocept Company Details
Table 130. Biocept Business Overview
Table 131. Biocept Immuno-oncology Diagnosis Product
Table 132. Biocept Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 133. Biocept Recent Developments
Table 134. Biodesix Inc Company Details
Table 135. Biodesix Inc Business Overview
Table 136. Biodesix Inc Immuno-oncology Diagnosis Product
Table 137. Biodesix Inc Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 138. Biodesix Inc Recent Developments
Table 139. BioFluidica Company Details
Table 140. BioFluidica Business Overview
Table 141. BioFluidica Immuno-oncology Diagnosis Product
Table 142. BioFluidica Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 143. BioFluidica Recent Developments
Table 144. BioGenex 40 bioMйrieux Company Details
Table 145. BioGenex 40 bioMйrieux Business Overview
Table 146. BioGenex 40 bioMйrieux Immuno-oncology Diagnosis Product
Table 147. BioGenex 40 bioMйrieux Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 148. BioGenex 40 bioMйrieux Recent Developments
Table 149. Bio-Rad Company Details
Table 150. Bio-Rad Business Overview
Table 151. Bio-Rad Immuno-oncology Diagnosis Product
Table 152. Bio-Rad Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 153. Bio-Rad Recent Developments
Table 154. Bio-Techne Company Details
Table 155. Bio-Techne Business Overview
Table 156. Bio-Techne Immuno-oncology Diagnosis Product
Table 157. Bio-Techne Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 158. Bio-Techne Recent Developments
Table 159. Bristol-Myers Squibb Company Details
Table 160. Bristol-Myers Squibb Business Overview
Table 161. Bristol-Myers Squibb Immuno-oncology Diagnosis Product
Table 162. Bristol-Myers Squibb Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 163. Bristol-Myers Squibb Recent Developments
Table 164. Cancer Genetics Company Details
Table 165. Cancer Genetics Business Overview
Table 166. Cancer Genetics Immuno-oncology Diagnosis Product
Table 167. Cancer Genetics Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 168. Cancer Genetics Recent Developments
Table 169. Caris Molecular Diagnostics Company Details
Table 170. Caris Molecular Diagnostics Business Overview
Table 171. Caris Molecular Diagnostics Immuno-oncology Diagnosis Product
Table 172. Caris Molecular Diagnostics Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 173. Caris Molecular Diagnostics Recent Developments
Table 174. CellMax Life Company Details
Table 175. CellMax Life Business Overview
Table 176. CellMax Life Immuno-oncology Diagnosis Product
Table 177. CellMax Life Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 178. CellMax Life Recent Developments
Table 179. Charles River Laboratories Company Details
Table 180. Charles River Laboratories Business Overview
Table 181. Charles River Laboratories Immuno-oncology Diagnosis Product
Table 182. Charles River Laboratories Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 183. Charles River Laboratories Recent Developments
Table 184. Chronix Biomedical Company Details
Table 185. Chronix Biomedical Business Overview
Table 186. Chronix Biomedical Immuno-oncology Diagnosis Product
Table 187. Chronix Biomedical Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 188. Chronix Biomedical Recent Developments
Table 189. Circulogene Company Details
Table 190. Circulogene Business Overview
Table 191. Circulogene Immuno-oncology Diagnosis Product
Table 192. Circulogene Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 193. Circulogene Recent Developments
Table 194. Clearbridge BioMedics Company Details
Table 195. Clearbridge BioMedics Business Overview
Table 196. Clearbridge BioMedics Immuno-oncology Diagnosis Product
Table 197. Clearbridge BioMedics Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 198. Clearbridge BioMedics Recent Developments
Table 199. Clinical Genomics Company Details
Table 200. Clinical Genomics Business Overview
Table 201. Clinical Genomics Immuno-oncology Diagnosis Product
Table 202. Clinical Genomics Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 203. Clinical Genomics Recent Developments
Table 204. Pfizer Company Details
Table 205. Pfizer Business Overview
Table 206. Pfizer Immuno-oncology Diagnosis Product
Table 207. Pfizer Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 208. Pfizer Recent Developments
Table 209. Promega Company Details
Table 210. Promega Business Overview
Table 211. Promega Immuno-oncology Diagnosis Product
Table 212. Promega Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 213. Promega Recent Developments
Table 214. Protagen Diagnostics Company Details
Table 215. Protagen Diagnostics Business Overview
Table 216. Protagen Diagnostics Immuno-oncology Diagnosis Product
Table 217. Protagen Diagnostics Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 218. Protagen Diagnostics Recent Developments
Table 219. Qiagen Company Details
Table 220. Qiagen Business Overview
Table 221. Qiagen Immuno-oncology Diagnosis Product
Table 222. Qiagen Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 223. Qiagen Recent Developments
Table 224. Quanterix Company Details
Table 225. Quanterix Business Overview
Table 226. Quanterix Immuno-oncology Diagnosis Product
Table 227. Quanterix Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 228. Quanterix Recent Developments
Table 229. Rarecells SAS Company Details
Table 230. Rarecells SAS Business Overview
Table 231. Rarecells SAS Immuno-oncology Diagnosis Product
Table 232. Rarecells SAS Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 233. Rarecells SAS Recent Developments
Table 234. Roche Diagnostics Company Details
Table 235. Roche Diagnostics Business Overview
Table 236. Roche Diagnostics Immuno-oncology Diagnosis Product
Table 237. Roche Diagnostics Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 238. Roche Diagnostics Recent Developments
Table 239. Siemens Company Details
Table 240. Siemens Business Overview
Table 241. Siemens Immuno-oncology Diagnosis Product
Table 242. Siemens Revenue in Immuno-oncology Diagnosis Business (2018-2023) & (US$ Million)
Table 243. Siemens Recent Development
Table 244. Research Programs/Design for This Report
Table 245. Key Data Information from Secondary Sources
Table 246. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Immuno-oncology Diagnosis Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Immuno-oncology Diagnosis Market Share by Type: 2022 VS 2029
Figure 3. PCR Features
Figure 4. NGS Features
Figure 5. Immunoassay Features
Figure 6. Global Immuno-oncology Diagnosis Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Immuno-oncology Diagnosis Market Share by Application: 2022 VS 2029
Figure 8. Research Case Studies
Figure 9. Diagnostics Case Studies
Figure 10. Immuno-oncology Diagnosis Report Years Considered
Figure 11. Global Immuno-oncology Diagnosis Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Immuno-oncology Diagnosis Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Immuno-oncology Diagnosis Market Share by Region: 2022 VS 2029
Figure 14. Global Immuno-oncology Diagnosis Market Share by Players in 2022
Figure 15. Global Top Immuno-oncology Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-oncology Diagnosis as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Immuno-oncology Diagnosis Revenue in 2022
Figure 17. North America Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Immuno-oncology Diagnosis Market Share by Type (2018-2029)
Figure 19. North America Immuno-oncology Diagnosis Market Share by Application (2018-2029)
Figure 20. North America Immuno-oncology Diagnosis Market Share by Country (2018-2029)
Figure 21. United States Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Immuno-oncology Diagnosis Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Immuno-oncology Diagnosis Market Share by Type (2018-2029)
Figure 25. Europe Immuno-oncology Diagnosis Market Share by Application (2018-2029)
Figure 26. Europe Immuno-oncology Diagnosis Market Share by Country (2018-2029)
Figure 27. Germany Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Immuno-oncology Diagnosis Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Immuno-oncology Diagnosis Market Share by Type (2018-2029)
Figure 35. China Immuno-oncology Diagnosis Market Share by Application (2018-2029)
Figure 36. Asia Immuno-oncology Diagnosis Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Immuno-oncology Diagnosis Market Share by Type (2018-2029)
Figure 38. Asia Immuno-oncology Diagnosis Market Share by Application (2018-2029)
Figure 39. Asia Immuno-oncology Diagnosis Market Share by Region (2018-2029)
Figure 40. Japan Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Share by Country (2018-2029)
Figure 50. Brazil Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. 10x Genomics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 57. Abbott Laboratories Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 58. Abcam Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 59. Adaptive Biotechnologies Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 60. Aethlon Medical Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 61. Agena Bioscience Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 62. Angle plc Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 63. Apocell Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 64. ARUP Laboratories Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 65. Beckman Coulter Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 66. Becton Dickinson Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 67. Bioarray Genetics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 68. BioCartis Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 69. Biocept Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 70. Biodesix Inc Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 71. BioFluidica Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 72. BioGenex 40 bioMйrieux Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 73. Bio-Rad Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 74. Bio-Techne Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 75. Bristol-Myers Squibb Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 76. Cancer Genetics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 77. Caris Molecular Diagnostics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 78. CellMax Life Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 79. Charles River Laboratories Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 80. Chronix Biomedical Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 81. Circulogene Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 82. Clearbridge BioMedics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 83. Clinical Genomics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 84. Pfizer Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 85. Promega Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 86. Protagen Diagnostics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 87. Qiagen Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 88. Quanterix Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 89. Rarecells SAS Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 90. Roche Diagnostics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 91. Siemens Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
Figure 1. Global Immuno-oncology Diagnosis Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Immuno-oncology Diagnosis Market Share by Type: 2022 VS 2029
Figure 3. PCR Features
Figure 4. NGS Features
Figure 5. Immunoassay Features
Figure 6. Global Immuno-oncology Diagnosis Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Immuno-oncology Diagnosis Market Share by Application: 2022 VS 2029
Figure 8. Research Case Studies
Figure 9. Diagnostics Case Studies
Figure 10. Immuno-oncology Diagnosis Report Years Considered
Figure 11. Global Immuno-oncology Diagnosis Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Immuno-oncology Diagnosis Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Immuno-oncology Diagnosis Market Share by Region: 2022 VS 2029
Figure 14. Global Immuno-oncology Diagnosis Market Share by Players in 2022
Figure 15. Global Top Immuno-oncology Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-oncology Diagnosis as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Immuno-oncology Diagnosis Revenue in 2022
Figure 17. North America Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Immuno-oncology Diagnosis Market Share by Type (2018-2029)
Figure 19. North America Immuno-oncology Diagnosis Market Share by Application (2018-2029)
Figure 20. North America Immuno-oncology Diagnosis Market Share by Country (2018-2029)
Figure 21. United States Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Immuno-oncology Diagnosis Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Immuno-oncology Diagnosis Market Share by Type (2018-2029)
Figure 25. Europe Immuno-oncology Diagnosis Market Share by Application (2018-2029)
Figure 26. Europe Immuno-oncology Diagnosis Market Share by Country (2018-2029)
Figure 27. Germany Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Immuno-oncology Diagnosis Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Immuno-oncology Diagnosis Market Share by Type (2018-2029)
Figure 35. China Immuno-oncology Diagnosis Market Share by Application (2018-2029)
Figure 36. Asia Immuno-oncology Diagnosis Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Immuno-oncology Diagnosis Market Share by Type (2018-2029)
Figure 38. Asia Immuno-oncology Diagnosis Market Share by Application (2018-2029)
Figure 39. Asia Immuno-oncology Diagnosis Market Share by Region (2018-2029)
Figure 40. Japan Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Immuno-oncology Diagnosis Market Share by Country (2018-2029)
Figure 50. Brazil Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Immuno-oncology Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. 10x Genomics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 57. Abbott Laboratories Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 58. Abcam Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 59. Adaptive Biotechnologies Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 60. Aethlon Medical Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 61. Agena Bioscience Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 62. Angle plc Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 63. Apocell Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 64. ARUP Laboratories Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 65. Beckman Coulter Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 66. Becton Dickinson Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 67. Bioarray Genetics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 68. BioCartis Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 69. Biocept Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 70. Biodesix Inc Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 71. BioFluidica Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 72. BioGenex 40 bioMйrieux Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 73. Bio-Rad Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 74. Bio-Techne Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 75. Bristol-Myers Squibb Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 76. Cancer Genetics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 77. Caris Molecular Diagnostics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 78. CellMax Life Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 79. Charles River Laboratories Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 80. Chronix Biomedical Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 81. Circulogene Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 82. Clearbridge BioMedics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 83. Clinical Genomics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 84. Pfizer Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 85. Promega Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 86. Protagen Diagnostics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 87. Qiagen Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 88. Quanterix Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 89. Rarecells SAS Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 90. Roche Diagnostics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 91. Siemens Revenue Growth Rate in Immuno-oncology Diagnosis Business (2018-2023)
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
